Study #2021-0733
A pilot study to determine the brain and cognitive effects of immune checkpoint inhibitor therapy in patients with melanoma as well as the association of this neurotoxicity with changes in cytokines in the fecal microbiome
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Pilot study of ICI-related cognitive effects in melanoma
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Study phase:
Not applicable
Physician name:
Jeffrey Wefel
Department:
Neuro-Oncology
For general questions about clinical trials:
1-888-597-3084
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.